|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Revenue | ||
| Cost of goods sold | ||
| Gross Profit | ||
| Operating expenses: | ||
| Research and development | ||
| Selling, general and administrative | ||
| Total operating expenses | ||
| Loss from operations | ||
| Other income (expense), net: | ||
| Interest income, net | ||
| Change in fair value of notes payable | ||
| Change in fair value of warrant liabilities | ||
| Other expense, net | ||
| Total other income (expense), net | ||
| Net loss and comprehensive loss | ||
| Accretion of dividends on convertible preferred stock | ||
| Net loss attributable to common stockholders | ||
| Net loss per share attributable to common stockholders, basic | ||
| Net loss per share attributable to common stockholders, diluted | ||
| Weighted-average number of common shares outstanding, basic | ||
| Weighted-average number of common shares outstanding, diluted |
Loading...
